A few years ago, there were many failures in phase III trials due to suboptimal dosing. PK/PD modeling tools are helping change that.
Link to Article
Drug Discovery and Development
|
|
||||
|
Modeling Success in PK/PD Testing
by
Alex Hsieh on behalf of Professor Henry Wang
on Mon 13 Feb 2006 11:07 PM EST | Permanent Link
| Cosmos
No comments found.
|
Search
Links
|
|||